← Back to Clinical Trials
Recruiting NCT06678880

NCT06678880 Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06678880
Status Recruiting
Phase —
Sponsor University of California, San Diego
Condition Depression
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-03-11
Primary Completion 2028-12

Eligibility & Interventions

Sex Female only
Min Age 45 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Phase Advanced Intervention (PAI)Phase Delay Intervention (PDI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-03-11 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

\*\*Participants must live in San Diego County\*\* The purpose of this study is to learn more about an experimental Sleep \& Light Intervention (SALI) for menopausal mood changes or depression. Researchers want to find out whether adjusting the body's internal clock-which helps regulate sleep, hormones, mood, and energy- can improve symptoms such as depression, poor sleep, and low energy during menopause.

Eligibility Criteria

Inclusion Criteria: * Women aged 45-75 years old * Experiencing significant down, sad or hopeless feelings that are affecting their daily life * These mood changes started or got worse during the menopause transition * Irregular or no menstrual cycle for at least 6 months * Non-smoking * Located in San Diego County Exclusion Criteria: * Untreated sleep apnea * Migraine headaches that are triggered or worsened by bright light * Currently suicidal or psychotic * History of bipolar disorder * A medical condition or job where fatigue or changes in sleep schedule could be unsafe * Planning to start, stop, or change medications in the next 4 months

Contact & Investigator

Central Contact

Jennifer A Perrott, MSW

✉ jperrott@health.ucsd.edu

📞 (407) 619-9441

Principal Investigator

Barbara Parry, M.D.

PRINCIPAL INVESTIGATOR

University of California, San Diego

Frequently Asked Questions

Who can join the NCT06678880 clinical trial?

This trial is open to female participants only, aged 45 Years or older, up to 75 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06678880 currently recruiting?

Yes, NCT06678880 is actively recruiting participants. Contact the research team at jperrott@health.ucsd.edu for enrollment information.

Where is the NCT06678880 trial being conducted?

This trial is being conducted at San Diego, United States.

Who is sponsoring the NCT06678880 clinical trial?

NCT06678880 is sponsored by University of California, San Diego. The principal investigator is Barbara Parry, M.D. at University of California, San Diego. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology